AstraZeneca Personalized Medicine Team has 10 Projects In The Clinic - McHale
This article was originally published in The Pink Sheet Daily
Executive Summary
Duncan McHale joined the firm in May as personalized health care medical director.
You may also be interested in...
Personalized Medicine Is Closer Than You Think, FDA’s Throckmorton Says
Personalized medicine should be adopted as a prospective strategy in drug development rather than primarily serving as a tool to salvage failing drug candidates, participants at FDA's Science Forum suggested
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.